Granisetron: all 62 studies that test it

Page 1 of 1. Open to participants first (4), then studies with results posted, then the rest; newest registration first within each.

• Granisetron Combined With Dexamethasone or Metoclopramide for PONV Prevention After Laparoscopic CholecystectomyNot yet recruitingNCT07360431Phase 4
• Intravenous Granisetron Vs Dexmedetomidine on Postspinal in the Cesarean Section.Enrolling by invitationNCT06762860Not applicable
• Comparative Study Between Intravenous Granisetron and Ondansetron on Their Effect on Hemodynamics and Shivering After Spinal Anesthesia in Elective Cesarean DeliveryRecruitingNCT06437236Not applicable
• Clonidine Versus Granisetron for Shivering PrevensionRecruitingNCT06031090Phase 2
• Oral Akynzeo® vs Standard of Care in Preventing CINV in High-risk MEC Patients (MyRisk)CompletedNCT04817189Phase 4Results posted
• Pharmacogenomics and Post-Operative Nausea and VomitingCompletedNCT03503292Phase 4Results posted
• Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) ProphylaxisCompletedNCT02625181Not applicableResults posted
• Granisetron Transdermal Patch for Prevention of Postoperative Nausea and VomitingCompletedNCT02457195Phase 2Results posted
• Sancuso® for Gastroparesis: An Open Label Study.CompletedNCT01989221Phase 3Results posted
• Oral Ondansetron Versus Transdermal Granisetron (Sancuso) for Women With Cervical, Endometrial or Vaginal Cancer Receiving Pelvic ChemoradiationCompletedNCT01536392Phase 3Results posted
• Aprepitant and Granisetron for the Prophylaxis of Radiation Induced Nausea and Vomiting - A Pilot StudyTerminatedNCT01183481Phase 2Results posted
• Granisetron 1 mg Tablets Under Fasting ConditionsCompletedNCT00834717Phase 1Results posted
• Granisetron 1 mg Tablets, Non-fastingCompletedNCT00834522Phase 1Results posted
• Phase 2 Study of Efficacy, Tolerability, and Safety of Intranasal Granisetron for Chemo-Induced Nausea and VomitingCompletedNCT00787566Phase 2Results posted
• Prevention of Delayed Nausea A Phase III Double-Blind Placebo-Controlled Clinical TrialCompletedNCT00475085Phase 3Results posted
• Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell TransplantCompletedNCT00293384Not applicableResults posted
• A Study of Kytril (Granisetron) in the Prevention of Post-Operative Nausea and Vomiting (PONV) in Pediatric Subjects Undergoing Tonsillectomy or AdenotonsillectomyCompletedNCT00231478Phase 4Results posted
• Occlusal Splint Combined With Granisetron Injection for Management of Myofascial Pain Related to Temporomandibular DisordersActive, not recruitingNCT07401745Phase 4
• Granisetron Versus Pethidine in Treatment of Post Spinal Shivering in Cesarean SectionsCompletedNCT06513806Phase 4
• Postoperative Intraperitoneal Pain Management Following Laparoscopic CholecystectomyCompletedNCT06281418Phase 3
• Granisetron Versus Ondansetron for Nausea and Vomiting in Pediatric Age GroupCompletedNCT06175806Not applicable
• Palonosetron vs Combination of Granisetron and Dexamethasone in Preventing PONV in Laparoscopic Cholecystectomy.CompletedNCT06043336Phase 4
• Postoperative Nausea and Vomiting in Laparoscopic Abdominal SurgeryStatus unknownNCT05632224Phase 4
• Safety Study of Repeat Doses of SUSTOL in AdultsActive, not recruitingNCT05434663Phase 4
• Granisetron Transdermal Patch System for Prevention of CINV by CapeOXStatus unknownNCT05325190Phase 2
• Role of Granisetron in Preventing Hypotension After Spinal Anesthesia With Levobupivacaine in Rheumatic Patients Undergoing Elective Cesarean SectionStatus unknownNCT05314257Phase 2/3
• Effects of Ondansetron, Metoclopramide and Granisetron on Perioperative Nausea and Vomiting in Patients Undergone Bariatric SurgeryCompletedNCT05087615Phase 3
• A COMPARATIVE STUDY BETWEEN 1MG AND 3 MG OF GRANISETRON IN THE PREVENTION OF POSTOPERATIVE NAUSEA AND VOMITING IN STRABISMUS OPHTHALMIC SURGERIES DURING GENERAL ANESTHESIACompletedNCT04918862Phase 3
• Granisteron Versus Metoclopramide in Laparoscopic CholecystectomyStatus unknownNCT04899817Phase 4
• The Effect of Intravenous Granisetron and Ondansetron in Patients Undergoing Cesarean SectionCompletedNCT04613726Phase 3
• Granisetron vs Granisetron and Dexamethasone on the Reduction of Postoperative Nausea and VomitingStatus unknownNCT04570592Phase 2
• Open Label Transdermal Granisetron to Relieve Chronic Nausea and EmesisWithdrawnNCT04501211Phase 2
• Granisetron Extended Release Injection (GERSC) for the Prevention of Chemotherapy-induced Nausea and VomitingWithdrawnNCT04085393Phase 2
• Adjunctive Granisetron Therapy in Patients With Sepsis or Septic ShockCompletedNCT03924518Phase 2
• Cisplatin Disposition and Kidney InjuryActive, not recruitingNCT03817970Phase 3
• Effect of Granisetron on Morphine Induced Pruritus in Cesarean SectionCompletedNCT03483870Phase 2
• Comp Granisetron Midazolam Comb in Lap ChildrenStatus unknownNCT03483350Phase 3
• Granisetron Effect on Hemodynamic Changes in Laparoscopic CholecystectomyCompletedNCT03180229Phase 4
• Granisetron in Diabetic Parturients Decrease Spinal Induced HypotensionCompletedNCT03091881Phase 4
• Treatment Algorithm for Nausea and Vomiting in the Palliative PhaseStatus unknownNCT03017391Phase 4
• Prevention of Spinal Induced Shivering During CSCompletedNCT02588547Phase 2
• Study on the Effect of Granisetron on Myofascial Pain in the Orofacial MusclesCompletedNCT02230371Phase 4
• Patient Satisfaction, Efficacy and Compliance of Antiemetic Patch vs Pill in Malignant Glioma PatientsWithdrawnNCT01952886Phase 2
• Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in CINV (Chemotherapy-induced Nausea and Vomiting) Associated With the Administration of MEC (Moderately Emetogenic Chemotherapy)Status unknownNCT01662687Phase 4
• Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in Chemotherapy-induced Nausea and Vomiting Associated With the Administration of Highly Emetogenic Chemotherapy (HEC)CompletedNCT01659775Phase 4
• Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 2 to 5 YearsWithdrawnNCT01596426Phase 1
• Pharmacokinetics and Safety of Sancuso and IV Granisetron in Pediatrics Aged 6 to 12 YearsWithdrawnNCT01596413Phase 1
• Granisetron Versus Ondansetron: Comparative Effects on ECG, QTcCompletedNCT01352130Phase 4
• Effect of External Heat on a Transdermal Granisetron Patch in Pharmacokinetics (PK) of Healthy SubjectsCompletedNCT01073696Phase 1
• Safety Study of Electrocardiogram (ECG) Effects of Sancuso® (Granisetron TDS)CompletedNCT00890565Phase 1
• PK, Tolerability and Safety of the Co-administration of Sancuso® (Transdermal Granisetron) and IV GranisetronCompletedNCT00873197Phase 1
• An Investigation on the Effect of Age and BMI on the Pharmacokinetics of Transdermal GranisetronCompletedNCT00868764Phase 1
• A Single Dose, 4-Period, 2-Treatment Replicate Design Bioequivalency Study of Granisetron Hydrochloride 1 mg Tablets Under Fasting ConditionsCompletedNCT00618254Not applicable
• A Single Dose, 4-Period, 2-Treatment Replicate Design Bioequivalency Study of Granisetron Hydrochloride 1 mg Tablets Under Fed ConditionsCompletedNCT00618111Not applicable
• The Pharmacokinetic Interaction Between Oral Casopitant and Oral Dolasetron, Granisetron or Rosiglitazone in SubjectsCompletedNCT00511823Phase 1
• Safety and Efficacy of Palonosetron in Preventing Chemotherapy-induced Nausea and VomitingCompletedNCT00503386Phase 2
• The Antigagging Effect of Granisetron (Kytril), an Antiemetic Drug, in Dental SituationsStatus unknownNCT00502437Not applicable
• Randomized Crossover Pharmacokinetic Evaluation of Subcutaneous Versus Intravenous Granisetron in Cancer PatientsCompletedNCT00450853Phase 2
• To Study the Safety and Effectiveness of a Granisetron Patch to Treat Chemotherapy-Induced Nausea and Vomiting (CINV)CompletedNCT00273468Phase 3
• Granisetron to Prevent Nausea and Vomiting After Chemotherapy in Patients With Malignant DiseaseStatus unknownNCT00005024Phase 3
• Lerisetron Compared With Granisetron in Preventing Nausea and Vomiting in Men Being Treated With Radiation Therapy for Stage I SeminomaStatus unknownNCT00004219Phase 3
• Drugs to Reduce the Side Effects of ChemotherapyCompletedNCT00003213Phase 3

← Granisetron overview